ARCHIVES

Gleevec Better Than Interferon For Newly Diagnosed CML

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science.

July 21, 2000

“Do What’s Right for People With Cancer”. Glick’s Credo

May 24, 1996

Upton Says NCI Must Take “Vigorous Role” In Prevention

February 3, 1978

DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan

June 10, 1988

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

Kurzrock and Ferrara Join UCSD Moores Cancer Center

January 25, 2013